![LumiraDx Gets CE Clearance for Five Different Products](https://www.g2intelligence.com/wp-content/uploads/2022/06/June17-2022.News_.LumiraDX-CE-Marks-iStock-1800x1250-1-1080x675.jpg)
LumiraDx Gets CE Clearance for Five Different Products
The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.
The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.
The move comes shortly after the FDA said it was going to decline some pre-submission requests to focus on pandemic-related diagnostics.
Effective June 1, the agency is once more accepting pre-submission requests for all in vitro diagnostics, including non-COVID-19 tests.
Two of the biggest merger and acquisition-related deals that came down in May involved BioMérieux and Sema4
Companies will explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.